Recent studies are consistent with our findings that eEF2K is highly expressed in a variety of solid tumors, including breast, pancreatic, lung, and hepatocellular carcinomas7–10, and may play a tumor-suppressive role in colorectal, endometrial, and gastric cancer tissues11–13. Here, EEF2K is linked to gastric cancer.